PDS Biotechnology Corp Intangible Assets, Net (Excluding Goodwill)
PDS Biotechnology Corp (PDSB) had Intangible Assets, Net (Excluding Goodwill) of $2.97 million as of 2020-12-31, per its 10-K filed 2021-03-18.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2021-03-18
- 2020-12-31: Intangible Assets, Net (Excluding Goodwill) $2.97M.
- 2020-09-30: Intangible Assets, Net (Excluding Goodwill) $2.97M.
- 2020-06-30: Intangible Assets, Net (Excluding Goodwill) $2.97M.
- 2020-03-31: Intangible Assets, Net (Excluding Goodwill) $2.97M.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2020-12-31 | $2.97M 10-K · filed 2021-03-18 | |
| 2020-09-30 | $2.97M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $2.97M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $2.97M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $2.97M 10-K · filed 2020-03-27 | |
| 2019-09-30 | $1.22M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.22M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $1.22M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $0.00 10-K · filed 2020-03-27 | $41.69K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |